IN2012DN00909A - - Google Patents
Info
- Publication number
- IN2012DN00909A IN2012DN00909A IN909DEN2012A IN2012DN00909A IN 2012DN00909 A IN2012DN00909 A IN 2012DN00909A IN 909DEN2012 A IN909DEN2012 A IN 909DEN2012A IN 2012DN00909 A IN2012DN00909 A IN 2012DN00909A
- Authority
- IN
- India
- Prior art keywords
- micro
- drug
- carrier
- released
- finally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0097—Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A drug delivery method is disclosed. A micro-carrier delivers an encapsulated drug directly to targeted sites without significant interactions with other components in the biological system. In one embodiment, a micro-carrier is first delivered to the general area for treatment. It then scans the area and selectively attaches itself to the cell site or organ location to be treated. Finally, the desired drug contained in the micro-earner is released to the attached site. In another embodiment, a micro-device is first used to process the general area to enhance differentiation in properties between cells and unhealthy cells. Drug is encapsulated in the micro-carrier to preferentially attach onto the targeted sites. Finally, drug is released from the micro-carrier onto the sites. Such microcarriers preferably contains multiple functions comprised of at least two of sensing, analyzing, logic processing, surface treatment, position detection, motion, injecting, delivering, cutting functions, removing functions, biodegradation and disintegration.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/498,698 US10105317B2 (en) | 2009-07-07 | 2009-07-07 | Method of drug delivery |
| PCT/US2010/041001 WO2011005720A1 (en) | 2009-07-07 | 2010-07-03 | Method of drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00909A true IN2012DN00909A (en) | 2015-04-03 |
Family
ID=43427656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN909DEN2012 IN2012DN00909A (en) | 2009-07-07 | 2010-07-03 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10105317B2 (en) |
| EP (1) | EP2451443B1 (en) |
| JP (2) | JP5950405B2 (en) |
| KR (1) | KR20120059495A (en) |
| CN (1) | CN102481259A (en) |
| AU (1) | AU2010270766B2 (en) |
| BR (1) | BR112012000420B8 (en) |
| CA (2) | CA3073148A1 (en) |
| IL (1) | IL217072A (en) |
| IN (1) | IN2012DN00909A (en) |
| NZ (1) | NZ597164A (en) |
| WO (1) | WO2011005720A1 (en) |
| ZA (1) | ZA201109514B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10624847B2 (en) * | 2011-08-02 | 2020-04-21 | AnPac BioMedical Science Co., Ltd. | Decomposable apparatus and methods for fabricating same |
| TWI630385B (en) | 2012-07-16 | 2018-07-21 | 昌和生物醫學科技（揚州）有限公司 | Devices and methods for enhanced detection and identification of diseases |
| CN107051597B (en) * | 2013-01-07 | 2019-08-09 | 安派科生物医学科技（丽水）有限公司 | The disease detection instrument of improvement |
| WO2014139482A1 (en) | 2013-03-15 | 2014-09-18 | Anpac Bio-Medical Science (Lishui) Co., Ltd. | Methods and apparatus for enhanced detection of diseases |
| CN105695327B (en) * | 2016-04-06 | 2018-09-07 | 京东方科技集团股份有限公司 | A kind of nanometer robot |
| WO2018056584A1 (en) | 2016-09-21 | 2018-03-29 | 삼성전자 주식회사 | Method for measuring skin condition and electronic device therefor |
| CN106448794B (en) * | 2016-10-14 | 2018-08-07 | 武汉理工大学 | Semiconductor microactuator nano-particle directed movement control method |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE261721T1 (en) | 1997-06-13 | 2004-04-15 | Nanopharm Ag | SYSTEM FOR THE TARGETED DELIVERY OF ACTIVE INGREDIENTS, METHOD FOR ITS PRODUCTION AND USE |
| US6165440A (en) | 1997-07-09 | 2000-12-26 | Board Of Regents, The University Of Texas System | Radiation and nanoparticles for enhancement of drug delivery in solid tumors |
| US20030007991A1 (en) | 1998-09-25 | 2003-01-09 | Masters David B. | Devices including protein matrix materials and methods of making and using thereof |
| US6773823B2 (en) | 2000-04-07 | 2004-08-10 | University Of New Orleans Research And Technology Foundation, Inc. | Sequential synthesis of core-shell nanoparticles using reverse micelles |
| US6663615B1 (en) * | 2001-09-04 | 2003-12-16 | The Ohio State University | Dual stage microvalve and method of use |
| JP4448441B2 (en) | 2002-06-05 | 2010-04-07 | ユニヴァーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイテッド | Ophthalmic medicine delivery system |
| JP2004231575A (en) * | 2003-01-30 | 2004-08-19 | Terumo Corp | Composition for delivering medicament to specific target site |
| EP1620145A4 (en) * | 2003-05-06 | 2010-08-25 | Becton Dickinson Co | A method for altering insulin pharmacokinetics |
| US20040236278A1 (en) | 2003-05-22 | 2004-11-25 | Atrium Medical Corp. | Therapeutic agent delivery |
| DK1704585T3 (en) | 2003-12-19 | 2017-05-22 | Univ North Carolina Chapel Hill | Methods for preparing isolated micro- and nanostructures using soft lithography or printing lithography |
| US7182894B2 (en) | 2004-03-12 | 2007-02-27 | Council Of Scientific & Industrial Research | Process for the preparation of free standing membranes |
| US8024036B2 (en) | 2007-03-19 | 2011-09-20 | The Invention Science Fund I, Llc | Lumen-traveling biological interface device and method of use |
| US7527668B2 (en) | 2004-07-08 | 2009-05-05 | Mitsubishi Materials Corporation | Method for manufacturing metal fine particles, metal fine particles manufactured thereby, and composition, light absorbing material and applied products containing the same |
| US20060040390A1 (en) | 2004-08-19 | 2006-02-23 | Minor John S Jr | Device, method, system, and program for intelligent in vivo cell-level chemical or genetic material delivery |
| JP2008532568A (en) * | 2005-01-18 | 2008-08-21 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Electronically controlled capsule |
| US20060283465A1 (en) | 2005-06-16 | 2006-12-21 | Nickel Janice H | Smart drug delivery system and a method of implementation thereof |
| EP2460868A3 (en) | 2006-01-06 | 2013-06-19 | National University of Singapore | Method of preparing nano-structured material(s) and uses thereof |
| US20080241264A1 (en) * | 2006-11-13 | 2008-10-02 | Solomon Research Llc | System and methods for collective nanorobotics for medical applications |
| US20080279764A1 (en) | 2007-03-09 | 2008-11-13 | Anthony Manganaro | Method and composition for treating cancer |
| WO2009018467A2 (en) | 2007-07-31 | 2009-02-05 | Massachusetts Institute Of Technology | Bio-sensing nanodevice |
-
2009
- 2009-07-07 US US12/498,698 patent/US10105317B2/en active Active
-
2010
- 2010-07-03 BR BR112012000420A patent/BR112012000420B8/en active IP Right Grant
- 2010-07-03 IN IN909DEN2012 patent/IN2012DN00909A/en unknown
- 2010-07-03 JP JP2012519653A patent/JP5950405B2/en active Active
- 2010-07-03 CN CN2010800395716A patent/CN102481259A/en active Pending
- 2010-07-03 KR KR1020127003283A patent/KR20120059495A/en active Search and Examination
- 2010-07-03 NZ NZ597164A patent/NZ597164A/en not_active IP Right Cessation
- 2010-07-03 WO PCT/US2010/041001 patent/WO2011005720A1/en active Application Filing
- 2010-07-03 EP EP10797693.8A patent/EP2451443B1/en active Active
- 2010-07-03 CA CA3073148A patent/CA3073148A1/en not_active Abandoned
- 2010-07-03 CA CA2766766A patent/CA2766766C/en active Active
- 2010-07-03 AU AU2010270766A patent/AU2010270766B2/en not_active Ceased
-
2011
- 2011-12-18 IL IL217072A patent/IL217072A/en active IP Right Grant
- 2011-12-22 ZA ZA2011/09514A patent/ZA201109514B/en unknown
-
2016
- 2016-06-02 JP JP2016110702A patent/JP6174757B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120059495A (en) | 2012-06-08 |
| JP2016193919A (en) | 2016-11-17 |
| ZA201109514B (en) | 2012-09-26 |
| JP6174757B2 (en) | 2017-08-02 |
| JP5950405B2 (en) | 2016-07-13 |
| AU2010270766B2 (en) | 2016-09-15 |
| BR112012000420A2 (en) | 2016-04-12 |
| BR112012000420B1 (en) | 2020-09-29 |
| EP2451443B1 (en) | 2017-05-03 |
| EP2451443A1 (en) | 2012-05-16 |
| CA3073148A1 (en) | 2011-01-13 |
| EP2451443A4 (en) | 2014-03-12 |
| NZ597164A (en) | 2014-07-25 |
| IL217072A (en) | 2017-06-29 |
| WO2011005720A1 (en) | 2011-01-13 |
| AU2010270766A1 (en) | 2012-01-19 |
| CA2766766C (en) | 2020-04-07 |
| US20110008446A1 (en) | 2011-01-13 |
| CN102481259A (en) | 2012-05-30 |
| BR112012000420B8 (en) | 2021-07-27 |
| CA2766766A1 (en) | 2011-01-13 |
| JP2012532675A (en) | 2012-12-20 |
| IL217072A0 (en) | 2012-02-29 |
| US10105317B2 (en) | 2018-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN00909A (en) | ||
| NZ596879A (en) | Tamper resistant dosage form comprising a matrix and melt - extruded particulates comprising a drug | |
| WO2010141377A3 (en) | Method and system for directing a localized biological response to an implant | |
| MX2013000201A (en) | Methods of delivering a health care active by administering personal health care articles comprising a filament. | |
| SG178577A1 (en) | Medical device for placement into a lumen and manufacturing method thereof | |
| WO2014167360A3 (en) | Method for treating a substrate made of animal fibers with solid particles and a chemical formulation | |
| WO2012019168A3 (en) | Engineered nucleic acids and methods of use thereof | |
| NZ710443A (en) | Method of identifying disease risk factors | |
| ZA201201176B (en) | Catheter comprising a protection system for aspirating,fragmenting and extracting removable material from hollow bodies and/or vessels,in particular of the human or animal body | |
| BRPI0716470A2 (en) | ULTRASONIC LIQUID TREATMENT AND DISTRIBUTION SYSTEM AND PROCESS | |
| WO2006113267A3 (en) | A fluid delivery system | |
| NZ703820A (en) | Permeant delivery system and methods for use thereof | |
| MX2013002488A (en) | Methods and compositions for delivering interleukin-1 receptor antagonist. | |
| MX2015011393A (en) | Modified poly(beta-amino ester)s for drug delivery. | |
| WO2008058683A3 (en) | Arrangement and method for the analysis of biological samples | |
| EP2552301A4 (en) | Method, system, and computer program product for improving the accuracy of glucose sensors using insulin delivery observation in diabetes | |
| WO2010091376A3 (en) | Devices and methods for perfusion therapy | |
| EP4032538A3 (en) | Methods and products for in vivo enzyme profiling | |
| EP2209495A4 (en) | Taz/wwtr1 for diagnosis and treatment of cancer | |
| WO2013136189A3 (en) | Methods and materials for treatment of pompe's disease | |
| PT3095458T (en) | Pharmaceutical composition for treating cancer comprising trypsinogen and chymotrypsinogen | |
| BRPI0916174A2 (en) | "display system, method and product of computer program" | |
| WO2007133750A3 (en) | Encapsulated nanoparticles for drug delivery | |
| NZ597269A (en) | Aptamer for chymase, and use thereof | |
| WO2010051383A3 (en) | A device and method for delivery of a drug depot |